4Aguilar_Salinas CA,Barrett H,Schonfeld G,et a/.Metabolic moders of action of the statins in the hyperlipoprot Einemias [J]. Atherosclreosis,1998,141:203-207.
1Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA,2001,288:430-436.
2Thompso PT. Clinical relevance of statins: instituting treatment early in caute coronary syndrome patients. Atherosclerosis, 2001, 2 Suppl:15-19.
3Aronow HD, Topol EJ, Roe MT, et al. Effects of lipid-lowering therpay on early mortality after acute coronary syndromes: an observational study. Lancet, 2001, 357:1063-1068.
4Spencer FA, Allegrone J, Goldberg RJ, et al. Association of statin therapy with outcomes of acute coronary syndrome: The GRACE study. Ann Intern Med, 2004, 140:857-866.
5Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastain on early recurrent ischemic events in acute ccoronary syndromes: the MIRACLE study. Arandomized controlled trial. JAMA, 2001, 285:1711-1718.
6Cannon CP, I Braunwald E, McCabe C, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med, 2004, 350:1495-504.
7de Lemos JA,Blazing MA,Wiviott SD et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes.JAMA, 2004, 292:1307-1316.
8Nissen SE. High-dose statins in acute coronary syndromes.Not just lipid levels. JAMA, 2004, l 292:1365-1367.
9Grundy SM, Cleeman JI, Merz NB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation, 2004, 110:227-239.
